Empagliflozin Protects Cardiac Mitochondrial Fatty Acid Metabolism
Researchers from the Laboratory of Pharmaceutical Pharmacology have shown that empagliflozin treatment preserves mitochondrial fatty acid oxidation in the heart under conditions of chronic lipid